StonvexLoading…
StonvexStonvexStonvexCore line items from BEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $8.77B | $8.48B | $7.85B | $8.28B |
Operating Income | $604.10M | $407.60M | $1.10B | $1.77B |
Net Income | $524.90M | $464.80M | $882.80M | $1.29B |
EPS (Diluted) | $0.91 | $0.85 | $1.72 | $2.53 |
Total Assets | $32.37B | $32.46B | $30.12B | $28.06B |
Total Liabilities | $18.18B | $17.90B | $16.55B | $14.24B |
Cash & Equivalents | $3.57B | $4.41B | $4.40B | $4.78B |
Free Cash Flow OCF − CapEx | $911.60M | $794.20M | $940.40M | $1.87B |
Shares Outstanding | 520.95M | 523.60M | 495.94M | 499.58M |